Oishi Yumiko, Spann Nathanael J, Link Verena M, Muse Evan D, Strid Tobias, Edillor Chantle, Kolar Matthew J, Matsuzaka Takashi, Hayakawa Sumio, Tao Jenhan, Kaikkonen Minna U, Carlin Aaron F, Lam Michael T, Manabe Ichiro, Shimano Hitoshi, Saghatelian Alan, Glass Christopher K
Department of Cellular and Molecular Medicine, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA; Department of Cellular and Molecular Medicine, Medical Research Institute, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.
Department of Cellular and Molecular Medicine, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Cell Metab. 2017 Feb 7;25(2):412-427. doi: 10.1016/j.cmet.2016.11.009. Epub 2016 Dec 29.
Macrophages play pivotal roles in both the induction and resolution phases of inflammatory processes. Macrophages have been shown to synthesize anti-inflammatory fatty acids in an LXR-dependent manner, but whether the production of these species contributes to the resolution phase of inflammatory responses has not been established. Here, we identify a biphasic program of gene expression that drives production of anti-inflammatory fatty acids 12-24 hr following TLR4 activation and contributes to downregulation of mRNAs encoding pro-inflammatory mediators. Unexpectedly, rather than requiring LXRs, this late program of anti-inflammatory fatty acid biosynthesis is dependent on SREBP1 and results in the uncoupling of NFκB binding from gene activation. In contrast to previously identified roles of SREBP1 in promoting production of IL1β during the induction phase of inflammation, these studies provide evidence that SREBP1 also contributes to the resolution phase of TLR4-induced gene activation by reprogramming macrophage lipid metabolism.
巨噬细胞在炎症过程的诱导期和消退期均发挥着关键作用。巨噬细胞已被证明能以一种依赖肝X受体(LXR)的方式合成抗炎脂肪酸,但这些物质的产生是否有助于炎症反应的消退期尚未明确。在此,我们确定了一个双相基因表达程序,该程序在Toll样受体4(TLR4)激活后12 - 24小时驱动抗炎脂肪酸的产生,并有助于下调编码促炎介质的mRNA。出乎意料的是,这个抗炎脂肪酸生物合成的晚期程序并不依赖LXR,而是依赖固醇调节元件结合蛋白1(SREBP1),并导致核因子κB(NFκB)与基因激活的解偶联。与之前确定的SREBP1在炎症诱导期促进白细胞介素1β(IL1β)产生的作用相反,这些研究提供了证据,表明SREBP1还通过重新编程巨噬细胞脂质代谢,对TLR4诱导的基因激活的消退期做出贡献。